Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Oncotarget
|
April 21, 2017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma
Krittiya Korphaisarn, Van Karlyle Morris, Michael J Overman, et al.
QJM : Monthly Journal of the Association of Physicians
|
March 20, 2018
Microscopic hematuria is a risk factor of incident chronic kidney disease in the Korean general population: a community-based prospective cohort study
H Kim, M Lee, M-U Cha, et al.
Medicine
|
November 3, 2017
Prevalence of depression and suicidal ideation increases proportionally with renal function decline, beginning from early stages of chronic kidney disease
Jong H Jhee, Eun Lee, Min-Uk Cha, et al.
British Journal of Cancer
|
August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma
Krittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.
JCO Precision Oncology
|
October 12, 2023
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing
Stefania Napolitano, Aparna R Parikh, Jason Henry, et al.
Cancer Chemotherapy and Pharmacology
|
June 14, 2023
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
Sarina A Piha-Paul, Chieh Tseng, Hai T Tran, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
December 8, 2010
Rapid aneuploidy screening with fluorescence in-situ hybridisation: is it a sufficiently robust stand-alone test for prenatal diagnosis?
A S T Lim, T H Lim, M M Hess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2015
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
M P Morelli, M J Overman, A Dasari, et al.
Plos One
|
March 8, 2017
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer
Amir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, et al.
Cancer
|
November 23, 2017
Physician interpretation of genomic test results and treatment selection
Lauren L Brusco, Chetna Wathoo, Kenna R Mills Shaw, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Oncotarget
|
April 21, 2017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma
Krittiya Korphaisarn, Van Karlyle Morris, Michael J Overman, et al.
QJM : Monthly Journal of the Association of Physicians
|
March 20, 2018
Microscopic hematuria is a risk factor of incident chronic kidney disease in the Korean general population: a community-based prospective cohort study
H Kim, M Lee, M-U Cha, et al.
Medicine
|
November 3, 2017
Prevalence of depression and suicidal ideation increases proportionally with renal function decline, beginning from early stages of chronic kidney disease
Jong H Jhee, Eun Lee, Min-Uk Cha, et al.
British Journal of Cancer
|
August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma
Krittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.
JCO Precision Oncology
|
October 12, 2023
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing
Stefania Napolitano, Aparna R Parikh, Jason Henry, et al.
Cancer Chemotherapy and Pharmacology
|
June 14, 2023
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
Sarina A Piha-Paul, Chieh Tseng, Hai T Tran, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
December 8, 2010
Rapid aneuploidy screening with fluorescence in-situ hybridisation: is it a sufficiently robust stand-alone test for prenatal diagnosis?
A S T Lim, T H Lim, M M Hess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2015
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
M P Morelli, M J Overman, A Dasari, et al.
Plos One
|
March 8, 2017
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer
Amir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, et al.
Cancer
|
November 23, 2017
Physician interpretation of genomic test results and treatment selection
Lauren L Brusco, Chetna Wathoo, Kenna R Mills Shaw, et al.
Page
of 6